Your browser doesn't support javascript.
loading
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy.
Kim, Sung-Bae; Do, In-Gu; Tsang, Janice; Kim, Tae-You; Yap, Yoon-Sim; Cornelio, Gerardo; Gong, Gyungyub; Paik, Soonmyung; Lee, Suee; Ng, Ting-Ying; Park, Sarah; Oh, Ho-Suk; Chiu, Joanne; Sohn, Joohyuk; Lee, Moonhee; Choi, Young-Jin; Lee, Eun Mi; Park, Kyong-Hwa; Nathaniel, Christos; Ro, Jungsil.
Affiliation
  • Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Do IG; Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Tsang J; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
  • Kim TY; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Yap YS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Cornelio G; Department of Medicine, San Juan De Dios Hospital, Manila, Philippines.
  • Gong G; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Paik S; Department of Medical Oncology and Severance Biomedical Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Lee S; Department of Internal Medicine, Dong-A University Hospital, Busan, Korea.
  • Ng TY; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China.
  • Park S; The Center for Anti-Cancer Companion Diagnostics, Bio-MAX/ N-Bio, Seoul National University, Seoul, Korea.
  • Oh HS; Department of Hematology- Oncology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
  • Chiu J; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
  • Sohn J; Division of Medical Oncology, Yonsei Cancer Center, Seoul, Korea.
  • Lee M; Division of Hematology-Oncology, Inha University Hospital, Incheon, Korea.
  • Choi YJ; Department of Hematology- Oncology, Pusan National University Hospital, Busan, Korea.
  • Lee EM; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea.
  • Park KH; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
  • Nathaniel C; Novartis Pharmaceuticals Corporation, APSA, Midrand, South Africa.
  • Ro J; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Cancer Res Treat ; 51(4): 1527-1539, 2019 Oct.
Article in En | MEDLINE | ID: mdl-31163957
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Protein Kinase Inhibitors / Lapatinib Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Res Treat Year: 2019 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Protein Kinase Inhibitors / Lapatinib Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Res Treat Year: 2019 Document type: Article Country of publication: